Are you Dr. Patel?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 103 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
600 N Cattlemen Rd
Suite 200
Sarasota, FL 34232Phone+1 941-377-9993Fax+1 941-343-0026
Summary
- Dr. Manish Patel, MD is an oncologist in Sarasota, Florida. He is currently licensed to practice medicine in Florida. He is affiliated with HCA Florida Sarasota Doctors Hospital and Sarasota Memorial Hospital - Sarasota.
Education & Training
- University of South Florida MorsaniFellowship, Hematology and Medical Oncology, 2008 - 2011
- Vanderbilt University Medical CenterResidency, Internal Medicine, 2005 - 2008
- University of Miami Leonard M. Miller School of MedicineClass of 2005
Certifications & Licensure![](https://directory.doximity.com/assets/icons/icon-help-e9f0b148a1e6d1f037dde9f26f025c36bd7c99fd4fe31fd76792996fa2aa5e66.svg)
- FL State Medical License 2009 - 2027
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification OncoEMR, Altos Solutions, Inc., 2012-2014
Clinical Trials
- Safety Study of X-82 in Patients With Advanced Solid Tumors Start of enrollment: 2011 Feb 01
- A Rollover Study for Patients Who Participated in Other Romidepsin Protocols Start of enrollment: 2011 May 01
- Safety Study of VAL-083 in Patients With Recurrent Malignant Glioma Start of enrollment: 2011 Oct 01
- Join now to see all
Publications & Presentations
PubMed
- Phase Ib study of PRT543, an oral protein arginine methyltransferase 5 (PRMT5) inhibitor, in patients with advanced splicing factor-mutant myeloid malignancies.Jan Philipp Bewersdorf, Xiaoli Mi, Bin Lu, Andrew Kuykendall, David Sallman
Leukemia. 2025-01-24 - Open-Label, Multicenter, Phase I Study to Assess Safety and Tolerability of Adavosertib Plus Durvalumab in Patients with Advanced Solid Tumors.Manish R Patel, Gerald S Falchook, Judy S Wang, Esteban Rodrigo Imedio, Sanjeev Kumar
Targeted Oncology. 2025-01-01 - Pirtobrutinib monotherapy in Bruton tyrosine kinase inhibitor-intolerant patients with B-cell malignancies: results of the phase I/II BRUIN trial.Nirav N Shah, Michael Wang, Lindsey E Roeker, Krish Patel, Jennifer A Woyach
Haematologica. 2025-01-01
Press Mentions
- Groundbreaking New FDA-Approved Drug for Acute Leukemia First Administered at Florida Cancer Specialists & Research Institute Sarasota Drug Development UnitNovember 22nd, 2024
- Florida Cancer Specialists & Research Institute Presents Clinical Research Results at 2022 ASCO® Annual MeetingJune 3rd, 2022
- Sarah Cannon to Present Latest Cancer Research Insights at 2021 ASCO® Annual MeetingJune 4th, 2021
- Join now to see all